Preoperative leukocytosis imposes an increased risk of recurrence and death among patients with nonendometrioid endometrial carcinoma

International Journal of Gynecological Cancer

Volumn 23, Issue 2, 2013, Pages 312-317

  Worley, Michael J ^a   Nitschmann, Caroline C ^a   Shoni, Melina ^a   Rauh Hain, Jose Alejandro ^b   Williams, Kristina A ^c   Feltmate, Colleen M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Endometrial carcinoma; Nonendometrioid; Preoperative leukocytosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; LEUKOCYTE COUNT; LEUKOCYTOSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PREOPERATIVE LEUKOCYTOSIS; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY;

AGED; DEATH; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LEUKOCYTOSIS; MIDDLE AGED; PREOPERATIVE PERIOD; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84876243503     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31827da21b     Document Type: Article

References (21)

1. American Cancer Society. Cancer Facts and Figures 2012. Atlanta, GA: American Cancer Society; 2012.
2. Creasman WT, Odicino F, Maisonneuve P, et al. Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95(suppl 1):S105-S143.
3. Sherman ME, Bitterman P, Rosenshein NB, et al. Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol. 1992;16:600-610.
4. Levenback C, Burke TW, Silva E, et al. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC). Gynecol Oncol. 1992;46:317-321.
5. Mendivil A, Schuler KM, Gehrig PA. Non-endometrioid adenocarcinoma of the uterine corpus: A review of selected histological subtypes. Cancer Control. 2009;16:46-52.
6. Sagr ER, Denschlag D, Kerim-Dikeni A, et al. Prognostic factors and treatment-related outcome in patients with uterine papillary serous carcinoma. Anticancer Res. 2007;27:1213-1217.
7. Cirisano FD Jr, Robboy SJ, Dodge RK, et al. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Gynecol Oncol. 2000;77:55-65.
8. Brennan JT. Oncologic emergencies and paraneoplastic syndromes. Prim Care. 1987;14:365-379.
9. Ashour AA, Verschraegen CF, Kudelka AP, et al. Paraneoplastic syndromes of gynecologic neoplasms. J Clin Oncol. 1997;15:1272-1282.
10. Worley MJ Jr, Nitschmann CC, Shoni M, et al. The significance of preoperative leukocytosis in endometrial carcinoma. Gynecol Oncol. 2012;125:561-565. E-pub Mar 29, 2012.
11. Qiu MZ, Xu RH, Ruan DY, et al. Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China. Tumour Biol. 2010;31:633-641. E-pub Jul 23, 2010.
12. Qiu MZ, Yuan ZY, Luo HY, et al. Impact of pretreatment hematologic profile on survival of colorectal cancer patients. Tumour Biol. 2010;31:255-260. E-pub Mar 25, 2010.
13. Kasuga I, Makino S, Kiyokawa H, et al. Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer. 2001;92:2399-2405.
14. Mabuchi S, Matsumoto Y, Isohashi F, et al. Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer. Gynecol Oncol. 2011;122:25-32. E-pub Apr 22, 2011.
15. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103-104.
16. Lerner DL,Walsh CS, Cass I, et al. The prognostic significance of thrombocytosis in uterine papillary serous carcinomas. Gynecol Oncol. 2007;104:91-94. E-pub Aug 24, 2006.
17. Watanabe M, Katsuaki O, Ozeki Y, et al. Production of granulocyte-macrophage colony stimulating factor in a patient with metastatic chest wall large cell carcinoma. Jpn J Clin Oncol. 1998;28:559-562.
18. Sato K, Fujii Y, Ono M, et al. Production of interleukin 1 alphalike factor and colony-simulating factor by a squamous cell carcinoma of the thyroid (T3M-5) derived from a patient with a hypercalcemia and leukocytosis. Cancer Res. 1987;47:6474-6480.
19. Chen YM, Whang-Peng J, Liu JM, et al. Leukemoid reaction resulting from multiple cytokine production in metastatic muco-epidermoid carcinoma with central necrosis. Jpn J Clin Oncol. 1995;25:168-172.
20. Connor JP. Aggressive carcinosarcoma of the uterine cervix associated with high levels of granulocyte colony stimulating factor: Case report and laboratory correlates. Gynecol Oncol. 2006;103:349-353. E-pub Jun 16, 2006.
21. Gutschalk CM, Herold-Mende CC, Fusenig NE, et al. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo. Cancer Res. 2006;66:8026-8036.